Harrington-Smith Kristen 4
4 · eFFECTOR Therapeutics, Inc. · Filed Jun 22, 2023
Insider Transaction Report
Form 4
Harrington-Smith Kristen
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-22+20,000→ 20,000 totalExercise: $0.82Exp: 2033-06-21→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest in full on the earlier to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date.